What is LeoMed?
LeoMed is a customizable health monitoring platform designed to empower healthcare professionals. It provides access to hundreds of connected biometric devices and features a no-code care journey creator, enabling care teams to enhance patient engagement and outcomes through personalized communication pathways, questionnaires, tasks, and videos. The platform's unique approach allows care teams, researchers, and administrators to tailor health monitoring to their specific objectives, rather than imposing a rigid system. With a team boasting over 20 years of expertise in clinical fields, telehealth, IT, and cybersecurity, and supported by a strong board, LeoMed is well-positioned to meet institutional monitoring goals.
How much funding has LeoMed raised?
LeoMed has raised a total of $2.8M across 1 funding round:
Seed
$2.8M
Seed (2025): $2.8M with participation from Precicom Technologies
Key Investors in LeoMed
Precicom Technologies
Precicom Technologies Inc. is a company operating within the Custom Software & IT Services industry, suggesting a potential focus on technology infrastructure and software solutions that could support LeoMed's platform development and integration.
What's next for LeoMed?
The recent major strategic investment signals a pivotal growth phase for LeoMed, likely focused on scaling its platform's reach and enhancing its technological capabilities. This capital infusion will probably be directed towards expanding its market presence, further developing its no-code creator, and integrating more advanced biometric devices. The company's emphasis on empowering care teams suggests a strategy centered on partnerships and enterprise adoption within the healthcare ecosystem. LeoMed's trajectory indicates a strong potential for innovation in personalized patient monitoring and telehealth solutions.
See full LeoMed company page
